Abaloparatide vs CJC-1295

A side-by-side comparison from PeptideSciences101, the open peptide reference.

Overview

Abaloparatide is primarily a bone & joint peptide, while CJC-1295 is used for performance & growth.

This page compares Abaloparatide and CJC-1295 across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.

Side-by-side comparison

AbaloparatideCJC-1295
CategoryBone & JointPerformance & Growth
Regulatory status (US)FDA approvedResearch use only
Typical dosage80 mcg1-2 mg
Frequencydailyweekly
Reported benefitsBone building, osteoporosis treatment, reduced fracture riskIncreased muscle mass, fat loss, improved recovery, better sleep, enhanced bone density
Reported side effectsSimilar to teriparatide but milderWater retention, joint pain, potential insulin resistance with prolonged use

Key differences

Primary use. Abaloparatide is categorised under Bone & Joint, while CJC-1295 falls under Performance & Growth. Their differing categories mean they are usually chosen for different goals rather than as direct substitutes.

Regulatory status. Abaloparatide: FDA-approved. CJC-1295: not FDA-approved; treated as a research compound.

Dosing. Abaloparatide is typically dosed at 80 mcg (daily). CJC-1295 is typically dosed at 1-2 mg (weekly).

Can you stack them?

Some protocols combine peptides, but stacking Abaloparatide and CJC-1295 has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.

Frequently asked questions

What is the difference between Abaloparatide and CJC-1295?
Abaloparatide is primarily a bone & joint peptide, while CJC-1295 is used for performance & growth. Abaloparatide is FDA-approved for one or more indications, whereas CJC-1295 is not FDA-approved; generally classified as a research compound.
What is Abaloparatide used for?
Advanced bone anabolic.
What is CJC-1295 used for?
Growth hormone, muscle mass, fat loss.
Can you take Abaloparatide and CJC-1295 together?
Some users combine peptides within a single protocol, but stacking Abaloparatide and CJC-1295 has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.
Is Abaloparatide or CJC-1295 FDA-approved?
Abaloparatide is FDA-approved for one or more indications. CJC-1295 is not FDA-approved; generally classified as a research compound.

Read the full articles

  • Abaloparatide — full monograph: mechanism, research, dosing & references
  • CJC-1295 — full monograph: mechanism, research, dosing & references

More Bone & Joint comparisons

Abaloparatide compared across categories

← All peptide comparisons